Digital Psychotherapeutics Market Size Drives at 28.24% CAGR by 2034, reports Towards Healthcare

The global digital psychotherapeutics market size is calculated at USD 2.17 billion in 2025 and is expected to reach around USD 20.66 billion by 2034, growing at a CAGR of 28.24% for the forecasted period.

Ottawa, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The global digital psychotherapeutics market size was valued at USD 1.69 billion in 2024 and is predicted to hit around USD 20.66 billion by 2034, rising at a 28.24% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.

This market is rising due to growing mental health awareness, increasing smartphone penetration, and strong clinical validation of cost-effective, scalable digital therapies.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5530

Key Takeaways

North America led the digital psychotherapeutics market in 2024.
Asia Pacific is estimated to grow at the fastest rate in the market during the forecast period.
By solution, the combination therapy segment held the major share of the market in 2024 and is expected to grow at the fastest CAGR during 2025-2034.
By solution, the monotherapy segment is expected to grow at a significant rate in the coming years.
By application, the treatment segment dominated the market and is estimated to grow at the highest CAGR during the predicted timeframe.
By application, the management segment is expected to grow at a significant rate in the coming years.
By disease indication, the phobias and anxiety segment held a dominant presence in the market in 2024.
By disease indication, the psychotic disorders segment is expected to grow at a lucrative rate between 2025 and 2034.
By business model, the direct-to-patients segment dominated the market in 2024.
By business model, the B2B segment is estimated to grow at the highest CAGR during the forecast period.

Market Overview:

The digital psychotherapeutics industry is experiencing a radical revolution, creating a new paradigm for delivering mental health care. The increase in demand for personalized, affordable mental health solutions has made digital therapeutics, anything from an app-based therapy to an AI therapy, a more obvious mainstream adjuvant or stand-alone treatment.

This sector will experience considerable growth in the foreseeable future, largely due to improving global mental health literacy, escalated stress and anxiety worldwide, and a rapidly expanding digital infrastructure. The electronic format of evidence-based digital interventions appeals to both clinicians and patients due to increased convenience and compliance. Clients have the potential to be in control of how they manage their mood disorder, trauma, and addiction-related problems without leaving their homes and interacting with therapists at their discretion using new engaging data-driven tools.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Major Growth Drivers:

To summarize, global need for mental health services, and increased stress and isolation related to the pandemic, has led to fast-paced uptake of digital alternative resources.
In tandem with widespread digital access obtaining therapy tools through digitization and smartphone and other remote technologies is also possible, lowering the barrier for participating in therapy within communities with particularly underserved resources or where access is still limited.
There are numerous studies establishing evidence from randomized control trials and real-world data establishing strong clinical and health outcomes. Other pathways have emerged establishing credible and sustainable regulatory use of these models, including FDA clearances for some digital therapeutic products, and similar pathways that show a proof of concept for uptake into broader clinical care and reimbursement structures.
These new structures are also improving the cost to benefits ratio by making delivery of digital services easier and beyond the traditional value added of access to care, particularly in some levels of care where mental health systems are under an extraordinary burden.

Key Drifts:

Transformative Trends Influencing the Marketplace:

A key market shaping trend is personalization, which is powered by AI and machine learning and is a critical factor in the future of digital platforms; digital platforms now modify and adapt interventions based on user and therapist behaviors, users' moods, and wearables and biometrics to maximize treatment effects. Another critical trend is the utilization of gamification and interactivity to foster engagement and stimulate retention to increase adherence in the face of an ongoing dropout issue affecting digital health more broadly as a field. In addition, blended models exist that combine digital tools, with live therapist support, to offer the best of both worlds, personalized treatment leveraging the added social support of an in-person provider, but at reduced cost.

Significant Challenge:

Barriers in the digital psychotherapeutics market:

The digital psychotherapeutics market has many barriers, although it promises a fascinating route of growth. Privacy and security of sensitive data surrounding mental health is paramount. Users and regulators are worried about data misuse or breaches. The regulatory landscape across regions also disproportionately impacts expansion globally, some countries are paving the way; others have no clear pathways related to digital clinical tools.

Additionally, clinicians themselves aren't adopting digital therapies without full integration in their clinical workflows and EHRs, the clinical uptake of mental health professionals remains sporadic. Limitations to patient adherence to digital interventions also impede digital therapies, where patients do not become sufficiently motivated or have adequate support, they enter with initial enthusiasm but drop the tech-therapy very early.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Regional Analysis:

North America is leading the digital psychotherapeutics ecosystem. With some of the best digital infrastructure, smartphone saturation rates, and supportive regulatory frameworks, North America has a strong hold on the market. The number of FDA-approved digital therapeutics is growing, as is investment from venture capitalists and other private investors, and the network of telehealth support for digital therapeutics.

Asia-Pacific has been developing quickly, driven by mobile internet uptake, increasing mental health awareness, and supportive government funding to develop digital health services. China, India, and Australia are markets to watch for fast uptake, with increased uptake of digital tools being assisted by localized content, cost-sensitivity, and scalable platforms that increase the accessibility of mental healthcare services.

Segmental Insights

By Solution:

The combination therapy domain, which is the use of a digital tool alongside traditional face-to-face or teletherapy, dominates the space with clinical effectiveness while providing user comfort and trust by providing a human guiding component.

The monotherapy domain is gaining traction with the most increase, driven primarily by the advantage of user convenience and scalability and distilled costs, with both the numbers and the approval of clinical research studies were providing efficacy without the live therapist component.

By Application:

The treatment domain, where individuals use digital psychotherapeutics for a mental disorder as the primary (be it face-to-face, telehealth) treatment, is the strongest, given the validated outcomes, clinician recommendations, and defined protocols embedded in an app.

The management segment (adherence, prevention of relapse, and self-management) is growing the fastest, as users engage with digital tools as part of their habitual routines to promote mental health beyond the acute treatment phase.

By Disease Indication:

Phobias and anxiety remain the dominant in the market; a multitude of CBT-based apps for panic, generalized anxiety, and phobic conditions are seen as having strong evidence. The psychotic disorders segment is growing the fastest, as more sophisticated tools – including early detection, monitoring based on voice and guided cognitive interventions, emerge to assist schizophrenia, bipolar psychosis, and related disorders.

By Business Model:

Direct-to-patients is the greatest segment, as users download apps, subscribe and/or pay out-of-pocket for easy access to self-guided digital therapy. The B2B type of business model is growing the fastest, as insurance plans, clinics, and employers increasingly license digital psychotherapeutic platforms to expand mental health service scope and improve user accessibility to services at scale to their beneficiaries.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Recent Developments

In June 2025, Pear Therapeutics announced FDA clearance for its new AI-enhanced digital therapeutic for post-traumatic stress disorder, expanding its evidence-based platform for mental health applications.
In April 2025, Mindstrong Health launched a smartphone-based, passive-data-driven tool for early detection of relapse in psychotic disorders; this proactive solution integrates with clinical workflows to alert care teams.
In August 2025, SilverCloud Health rolled out a gamified anxiety management app tailored to young adults in the Asia-Pacific region, partnering with local universities for behavioral validation.

Digital Psychotherapeutics Market Key Players List

Big Health
Pear Therapeutics, Inc.
Omega Health
Iris Telehealth
Amwell
Kintsugi
Eleos Health
Lyra Health, Inc.
Quartet Health
Neuro Flow
Headspace

Browse More Insights of Towards Healthcare:

The global digital behavioral health market was valued at USD 27.9 billion in 2024, rising to USD 33.1 billion in 2025, and is projected to reach approximately USD 153.85 billion by 2034, expanding at a CAGR of 18.6% from 2025 to 2034.

The global digital health and wellness market stood at USD 498.99 billion in 2024, increased to USD 607.06 billion in 2025, and is expected to attain nearly USD 3,568.11 billion by 2034, growing at a CAGR of 21.92% between 2025 and 2034.

The global digital health insurance market was estimated at USD 3.57 trillion in 2024, advanced to USD 3.99 trillion in 2025, and is forecasted to hit about USD 11.11 trillion by 2034, registering a CAGR of 12.05% during the forecast period.

The global digital health monitoring devices market reached USD 5.23 billion in 2024, expanded to USD 6.22 billion in 2025, and is anticipated to achieve roughly USD 29.71 billion by 2034, witnessing a CAGR of 18.9% between 2025 and 2034.

The global digital mental health platforms market stood at USD 0.80 billion in 2024, grew to USD 0.89 billion in 2025, and is projected to reach nearly USD 2.49 billion by 2034, progressing at a CAGR of 12.37% from 2025 to 2034.

The global digital health automation market is on a strong growth trajectory, with revenues expected to scale significantly, potentially reaching hundreds of millions over the forecast period of 2025–2034.

The global digital brain health market was valued at USD 231.17 billion in 2024, climbed to USD 248.62 billion in 2025, and is forecasted to reach around USD 478.53 billion by 2034, advancing at a CAGR of 7.55% between 2025 and 2034.

The digital health tracking app market recorded a size of USD 16.11 billion in 2024, increased to USD 18.68 billion in 2025, and is expected to touch USD 67.97 billion by 2034, growing at a CAGR of 15.94% from 2025 to 2034.

The global pen injectors market was valued at USD 43.9 billion in 2024, rose to USD 46.65 billion in 2025, and is projected to reach nearly USD 79.37 billion by 2034, registering a CAGR of 6.34% during the forecast period.

The global healthcare biometrics market stood at USD 8.4 billion in 2024, expanded to USD 9.86 billion in 2025, and is anticipated to attain approximately USD 41.38 billion by 2034, growing at a CAGR of 17.34% between 2025 and 2034.

Segments Covered in the Report

By Type Solution Type

Monotherapy
Combination Therapy

By Application Type

Preventative
Management
Treatment

By Indication Type

Phobias and Anxiety
Psychotic Disorders

By Business Type

Direct to Patients
B2B

By Region

North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Latin America
- Brazil
- Mexico
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5530

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Our Trusted Data Partners

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.